Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Mas E
- Borrelli O
- Broekaert I
- Martin de-Carpi, J
- Dolinsek J
- Miele E
- Pienar C
- Thomassen RA
- Thomson M
- Tzivinikos C
- Benninga MA
Grupos
Abstract
Octreotide, a somatostatin analogue, has been used for more than 20 years in children with gastrointestinal bleeding, chylothorax or chylous ascites, intestinal lymphangiectasia, pancreatitis, intestinal dysmotility, and severe diarrhoea; however, until now, there is a lack of randomised clinical trials evaluating the efficacy of this compound in childhood. Hence, we aimed to review the literature in order to determine the evidence of its use and safety in children, using PubMed from 2000 to 2021 with the search terms "octreotide" and "children" and "bleeding or chylous ascites or chylothorax or acute pancreatitis or lymphangiectasia or diarrhoea or intestinal dysmotility".
Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Datos de la publicación
- ISSN/ISSNe:
- 0277-2116, 1536-4801
- Tipo:
- Article
- Páginas:
- 1-6
- PubMed:
- 34508049
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 0,919 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION WILEY
Citas Recibidas en Web of Science: 14
Documentos
- No hay documentos
Filiaciones
Keywords
- bleeding; children; chylous ascites; diarrhoea; ocreotide; somatostatin
Cita
Mas E,Borrelli O,Broekaert I,Martin de J,Dolinsek J,Miele E,Pienar C,KONINCKX CR,Thomassen RA,Thomson M,Tzivinikos C,Benninga MA. Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders. J. Pediatr. Gastroenterol. Nutr. 2021. 74. (1):p. 1-6. IF:3,355. (2).
Portal de investigación